Prosegur Cash S.A. (0RNO)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 0.674 |
|---|---|
| 52-week range | 0.590 – 0.747 |
| Return, 1 month / 3 months | +1.2% / −2.8% |
| Return, 1 year / 3 years | −8.6% / +44.7% |
| Trend | Uptrend |
| RSI (14) | 54 |
| Volatility (1 year) | 21.1% |
| Worst drawdown (1 year) | -19.7% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 5.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Prosegur Cash is a security company based in Madrid that handles physical cash and valuables for businesses and financial institutions. Its services include armoured transport of money, replenishing and servicing cash machines, counting and processing coins and notes, and managing cash for banks, retailers and other organisations. The company also offers related services such as payment solutions and secure logistics, and it operates in Spain, other European countries and Latin America.
On this site Prosegur Cash S.A. appears as a stock on the London Exchange (UK), code 0RNO, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Prosegur Cash S.A. (0RNO) trades on the London Exchange in UK. It last closed at EUR 0.674 on 21 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,865 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.6% and over the last three months it fell 2.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.8% | ||
| From 52-week high | -8.6% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.8% | ||
| 6-month return | 6.6% | ||
| 12-month return, skipping the last month | -9.6% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.7% | ||
| Liquidity | 9 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 6.7% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.1% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | +1.2% |
| 3 months | −2.8% |
| 6 months | +6.6% |
| 1 year | −8.6% |
| 3 years | +44.7% |
| 5 years | +24.0% |
Signals
| 50-day / 200-day average | 0.665 / 0.643 |
|---|---|
| Golden / death cross (60 days) | Golden, 54 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.017 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Nov 2025 | EUR 0.0343 |
| 13 Dec 2024 | EUR 0.0082 |
| 21 Oct 2024 | EUR 0.0082 |
| 19 Jul 2024 | EUR 0.0082 |
| 10 May 2024 | EUR 0.0082 |
| 24 Oct 2023 | EUR 0.0053 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.